Status:
RECRUITING
Validation of the French Version of the Prediction of the Alcohol Withdrawal Severity Scale (PAWSS)
Lead Sponsor:
Etablissement Public de Santé Barthélemy Durand
Conditions:
Addiction, Substance
Alcohol Use Disorder
Eligibility:
All Genders
18-60 years
Brief Summary
The goal of this observational study is to validate the French version of the PAWSS scale in a population of patients with Alcohol Use Disorders. Prediction of Alcohol Withdrawal Severity Scale (PAWSS...
Detailed Description
Context Alcohol use disorders (AUDs) are reported in 10-32% of hospitalized medical patients \[Nielsen et al. 1994; Smothers et al. 2004; Dolman and Hawkes 2005; Doering-Silveira et al. 2014\], in 23 ...
Eligibility Criteria
Inclusion Criteria:
- Male or female, aged 18 to 60 years
- Subjects with DSM-5 criteria for alcohol use disorders (AUD)
- Subjects hospitalized for scheduled withdrawal or patients developing alcohol withdrawal hospitalized for another reason.
- Subjects who understand French
- Subject affiliated to the French social security system
- Subject having given their written consent to the study
Exclusion Criteria:
- Subjects transferred from other hospitalization services for whom a withdrawal syndrome could have already been treated.
- Subjects scheduled for discharge within 48 hours.
- Subjects with known uncontrolled epilepsy.
- Subjects unable to understand the questionnaire.
- Subjects unable to give consent or not volunteering for the study.
- Subjects under guardianship or curatorship.
Key Trial Info
Start Date :
November 11 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2027
Estimated Enrollment :
545 Patients enrolled
Trial Details
Trial ID
NCT06675539
Start Date
November 11 2024
End Date
October 1 2027
Last Update
February 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Etablissement Public de Santé Barthélemy Durand
Étampes, France, 91150